Rowett Seminar

EpitogenX combines two mature transformative technologies, EpitoPredikt ™ and EpitoGen®. EpitoPredikt is an artificial intelligence software that can predict immunodominant epitopes. Whilst, EpitoGen is  a bioengineered scaffold developed to express and display individual or multiplexed peptides/subunits in their native conformation. Combined, the technologies will transform serology testing, peptide/subunit-based vaccines and therapeutics safety. The scaffold can also express immun-modulators such as cytokines, flagellins and proteins with short half-life for research and clinical use. Moreover, the scaffold can readily display nanobodies and provide the framework to undergo evolutionary maturation to improve specificity and sensitivity.